Hematology/ Oncology and Stem Cell Therapy
SJR0.506
GB
GBJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.506 | Q3 | 61.3% | |
| 2024 | — | — | 0.554 | Q2 | 65.7% | |
| 2023 | — | — | 0.601 | Q2 | 71.0% | |
| 2022 | — | — | 0.538 | Q2 | 68.6% | |
| 2021 | — | — | 0.457 | Q3 | 64.3% | |
| 2020 | — | — | 0.666 | Q2 | 74.8% | |
| 2019 | — | — | 0.580 | Q2 | 71.7% | |
| 2018 | — | — | 0.617 | Q2 | 71.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
1658-3876
ISSN
2589-0646
country
GBcoverage
2008-2025